Healthcare Business

Why Investors Shouldn’t Sleep on This Narcolepsy Study

Posted: December 3, 2019 at 9:40 am

Axsome Therapeutics Inc. (NASDAQ: AXSM) shares jumped early on Tuesday after the firm announced positive results from its midstage narcolepsy trial. Specifically, the results come from the Phase 2 Concert ...
Read Full Story »

Why This Atopic Dermatitis Study Was So Well Received

Posted: December 2, 2019 at 10:15 am

Aslan Pharmaceuticals Ltd. (NASDAQ: ASLN) shares jumped on Monday after the firm announced positive preliminary data from the lowest dose cohort of its ongoing multiple ascending dose study of ASLAN004 ...
Read Full Story »

Why This Seizure Treatment Could Be the Next Big Thing

Posted: December 2, 2019 at 9:40 am

Aquestive Therapeutics Inc. (NASDAQ: AQST) shares jumped early on Monday after the firm announced the completion of its rolling submission of a New Drug Application (NDA) to the U.S. Food ...
Read Full Story »

Major Biopharma Catalysts on the December FDA Calendar

Posted: November 29, 2019 at 10:40 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Big Pharma Short Sellers Hike Their Bets

Posted: November 27, 2019 at 9:00 am

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Run For Cover From Major Biotechs

Posted: November 27, 2019 at 8:40 am

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Starboard Value Stake Momentarily Shakes Up CVS

Posted: November 26, 2019 at 12:34 pm

A report Monday in the Wall Street Journal put a bit of air under shares of CVS Health Corp. (NYSE: CVS). The drugstore, pharmacy benefits manager, and health insurer has ...
Read Full Story »

What This Study For ANCA Vasculitis Means Going Forward

Posted: November 26, 2019 at 12:21 pm

ChemoCentryx, Inc. (NASDAQ: CCXI) shares more than tripled on Tuesday after the firm, in conjunction with Vifor Fresenius Medical Care Renal Pharma, announced positive topline data from its late-stage trial ...
Read Full Story »

Why This Newly FDA Approved Sickle Cell Treatment Will Be Huge

Posted: November 26, 2019 at 11:02 am

Global Blood Therapeutics, Inc. (NASDAQ: GBT) shares jumped on Tuesday after the firm announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta (voxelotor) tablets ...
Read Full Story »

Novartis Finally Comes Through With Its Acquisition of Medicines Co

Posted: November 25, 2019 at 10:02 am

Medicines Co. (NASDAQ: MDCO) shares shot up on Monday after it was reported that Novartis A.G. (NYSE: NVS) will be acquiring the firm. The transaction was unanimously approved by the ...
Read Full Story »

A Big Step Forward For the Treatment of ALS

Posted: November 25, 2019 at 9:44 am

Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares jumped on Monday after the firm announced that its treatment of amyotrophic lateral sclerosis (ALS), Exservan, received early-action approval from the U.S. Food and ...
Read Full Story »

Metastatic Melanoma Study Mixed Results Could Be a Positive

Posted: November 21, 2019 at 11:30 am

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced results from a subgroup analysis of metastatic melanoma patients in its Phase 2 study of lifileucel. These results were released in an abstract for ...
Read Full Story »

ProQR Therapeutics Takes a Big Step Forward With Its Latest FDA Approval

Posted: November 21, 2019 at 8:55 am

ProQR Therapeutics N.V. (NASDAQ: PRQR) shares jumped early on Thursday after the firm announced that it received Orphan Drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for ...
Read Full Story »

A Big Step Forward in the Fight Against Ovarian Cancer

Posted: November 20, 2019 at 1:25 pm

Aravive Inc. (NASDAQ: ARAV) shares skyrocketed on Wednesday after the firm announced early-stage data for its ovarian cancer treatment. Specifically, the results are from the ongoing Phase 1b portion of ...
Read Full Story »

Why This FDA Breakthrough Is a Big Deal for Recurrent Pericarditis Patients

Posted: November 20, 2019 at 11:15 am

Kiniksa Pharmaceuticals Ltd. (NASDAQ: KNSA) shares jumped on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for rilonacept for the treatment ...
Read Full Story »